Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trials LANCET NEUROLOGY Mignot, E., Mayleben, D., Fietze, I., Leger, D., Zammit, G., Bassetti, C. A., Pain, S., Kinter, D., Roth, T. 2022; 21 (2): 125-139

View details for Web of Science ID 000769111800014